Company Executives

Management Team

From Forms 3, 4 and 5 filed in the last 18 months

Officer	Age	In this role	Joined	Pay
Wei R Gao General Counsel Title from the Form 3 dated Mar 18, 2026	Not stated	Not stated	Not stated	Not reported
Kun Qian Global Controller Title from the Form 3 dated Mar 18, 2026	Not stated	Not stated	Not stated	Not reported
Hai Huang Global Chief Commercial Ofcr Title from the Form 3 dated Mar 18, 2026	Not stated	Not stated	Not stated	Not reported
Alexander A Zukiwski Global Chief Medical Officer Title from the Form 3 dated Mar 18, 2026	Not stated	Not stated	Not stated	Not reported
Chunhua Wang Chief Operating Officer Title from the Form 3 dated Mar 18, 2026	Not stated	Not stated	Not stated	Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

No proxy statement on record

Board of Directors comes from the company’s proxy statement. CASI Pharmaceuticals Inc has not filed one with the SEC.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. CASI Pharmaceuticals Inc has not filed one with the SEC.

Comments